• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2011 - 2021年中国浙江省脑膜炎球菌病的流行病学、携带情况、分离株的基因型特征及抗生素耐药性

The Epidemiology of Meningococcal Disease and Carriage, Genotypic Characteristics and Antibiotic Resistance of Isolates in Zhejiang Province, China, 2011-2021.

作者信息

Zhang Yunyi, Deng Xuan, Jiang Yan, Zhang Junyan, Zhan Li, Mei Lingling, Lu Hangjing, Yao Pingping, He Hanqing

机构信息

Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Front Microbiol. 2022 Jan 24;12:801196. doi: 10.3389/fmicb.2021.801196. eCollection 2021.

DOI:10.3389/fmicb.2021.801196
PMID:35140696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8819144/
Abstract

() remains a worldwide leading cause of epidemic meningitis. During 2011-July 2021, 55 meningococcal disease (MD) cases were reported with a case fatality rate of 5.45% in Zhejiang Province, China. The median age was 7 years. The annual incidence was 0.0017-0.0183 per 100,000 population. The highest age-specific incidence was observed in the group younger than 1 year. Serogroup was identified in 30 laboratory-confirmed MD cases, and MenB was most predominant. MenB was mainly observed in two age groups: younger than 5 and older than 35 years. MenB incidence was significantly increasing from 0.0018 per 100,000 in 2013 to 0.0070 per 100,000 in 2019. During 2015-2020, 17 positive samples were detected from 2,827 throat swabs from healthy population, of which 70.59% was MenB. Twenty multilocus sequence typing sequence types (STs) containing eight newly assigned STs (ST15881-ST15888) were determined in all isolates. Either in MD cases or in healthy population, MenB CC ST-4821 was the predominant ST. It was worth noting that two MenY CC ST-23 cases occurred in 2019 and 2021, respectively. MenY CC ST-23 MD cases increased gradually in China. Phylogeny results based on genome sequencing indicated that Chinese MenW CC ST-11 isolates were genetically linked and grouped together with Japanese isolates, separated from MenW CC ST-11 isolates from Saudi Arabia Hajj outbreak, Europe, South Africa, South America, North America, and Oceania. MenW CC ST-11 isolates from East Asia might have evolved locally. Antibiotic susceptibility tests revealed a relatively high resistance rate (22.86%) of isolates to penicillin. This study provided valuable data for Chinese public health authorities to grasp the temporal epidemiological characteristics of MD and healthy carriage.

摘要

()仍然是全球流行性脑膜炎的主要病因。2011年至2021年7月期间,中国浙江省报告了55例脑膜炎球菌病(MD)病例,病死率为5.45%。中位年龄为7岁。年发病率为每10万人0.0017至0.0183例。年龄特异性发病率最高的是1岁以下人群。在30例实验室确诊的MD病例中确定了血清群,其中B群脑膜炎奈瑟菌最为常见。B群脑膜炎奈瑟菌主要出现在两个年龄组:5岁以下和35岁以上。B群脑膜炎奈瑟菌发病率从2013年的每10万人0.0018例显著增至2019年的每10万人0.0070例。2015年至2020年期间,从2827份健康人群咽拭子中检测到17份阳性样本,其中70.59%为B群脑膜炎奈瑟菌。在所有分离株中确定了20种多位点序列分型序列类型(STs),其中包括8种新指定的STs(ST15881 - ST15888)。无论是在MD病例还是健康人群中,B群脑膜炎奈瑟菌复合群ST - 4821都是主要的ST。值得注意的是,2019年和2021年分别出现了2例Y群脑膜炎奈瑟菌复合群ST - 23病例。Y群脑膜炎奈瑟菌复合群ST - 23的MD病例在中国逐渐增加。基于基因组测序的系统发育结果表明,中国的W群脑膜炎奈瑟菌复合群ST - 11分离株在基因上相互关联,并与日本分离株归为一组,与来自沙特阿拉伯朝觐疫情、欧洲、南非、南美洲、北美洲和大洋洲的W群脑膜炎奈瑟菌复合群ST - 11分离株分开。东亚的W群脑膜炎奈瑟菌复合群ST - 11分离株可能在当地进化。抗生素敏感性试验显示,分离株对青霉素的耐药率相对较高(22.86%)。本研究为中国公共卫生当局掌握MD和健康带菌的时间流行病学特征提供了有价值的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6734/8819144/6edfd212e27e/fmicb-12-801196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6734/8819144/1579a4d4a660/fmicb-12-801196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6734/8819144/19f97e2b8fca/fmicb-12-801196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6734/8819144/6edfd212e27e/fmicb-12-801196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6734/8819144/1579a4d4a660/fmicb-12-801196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6734/8819144/19f97e2b8fca/fmicb-12-801196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6734/8819144/6edfd212e27e/fmicb-12-801196-g003.jpg

相似文献

1
The Epidemiology of Meningococcal Disease and Carriage, Genotypic Characteristics and Antibiotic Resistance of Isolates in Zhejiang Province, China, 2011-2021.2011 - 2021年中国浙江省脑膜炎球菌病的流行病学、携带情况、分离株的基因型特征及抗生素耐药性
Front Microbiol. 2022 Jan 24;12:801196. doi: 10.3389/fmicb.2021.801196. eCollection 2021.
2
Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease.对近期出现的与侵袭性脑膜炎球菌病相关的加拿大血清群 W 奈瑟菌 11 型克隆复合体分离株的全基因组分型。
Int J Infect Dis. 2018 Apr;69:55-62. doi: 10.1016/j.ijid.2018.01.019. Epub 2018 Feb 4.
3
Characterization of invasive Neisseria meningitidis isolates recovered from children in Turkey during a period of increased serogroup B disease, 2013-2017.对 2013-2017 年期间土耳其因 B 群血清型疾病增加而从儿童中分离出的侵袭性脑膜炎奈瑟菌的特征进行描述。
Vaccine. 2020 Apr 23;38(19):3545-3552. doi: 10.1016/j.vaccine.2020.03.024. Epub 2020 Mar 19.
4
Increase in ST-11 serogroup W invasive meningococcal disease in Canada, 2016-2018.2016 - 2018年加拿大ST-11血清群W型侵袭性脑膜炎球菌病增加。
Can Commun Dis Rep. 2019 Jun 6;45(6):164-169. doi: 10.14745/ccdr.v45i06a04.
5
Genomic characterization of Japanese meningococcal strains isolated over a 17-year period between 2003 and 2020 in Japan.2003年至2020年期间在日本分离出的日本脑膜炎球菌菌株的基因组特征。
Vaccine. 2023 Jan 9;41(2):416-426. doi: 10.1016/j.vaccine.2022.10.083. Epub 2022 Dec 2.
6
Genomic Surveillance of Invasive Meningococcal Disease During a National MenW Outbreak in Australia, 2017-2018.2017 - 2018年澳大利亚全国性W群脑膜炎球菌病暴发期间侵袭性脑膜炎球菌病的基因组监测
Open Forum Infect Dis. 2024 May 2;11(6):ofae249. doi: 10.1093/ofid/ofae249. eCollection 2024 Jun.
7
Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.台湾地区脑膜炎奈瑟菌的分子流行病学及全球流行克隆株的出现
BMC Infect Dis. 2006 Feb 15;6:25. doi: 10.1186/1471-2334-6-25.
8
Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates.多组份脑膜炎奈瑟菌 B 型疫苗在婴儿中引发针对遗传上不同的 C、W 和 Y 群侵袭性疾病分离株的交叉反应性免疫。
Vaccine. 2020 Nov 3;38(47):7542-7550. doi: 10.1016/j.vaccine.2020.09.050. Epub 2020 Oct 7.
9
Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Strains and Their Predicted Coverage by the 4CMenB Vaccine.2010 至 2014 年加拿大确认文化的侵袭性脑膜炎奈瑟菌病:B 群菌株的特征及 4CMenB 疫苗的预测覆盖范围
mSphere. 2020 Mar 4;5(2):e00883-19. doi: 10.1128/mSphere.00883-19.
10
Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.侵袭性、广泛传播、多样且不断扩展的B、C和W群脑膜炎奈瑟菌谱系的基因组解析
J Infect. 2015 Nov;71(5):544-52. doi: 10.1016/j.jinf.2015.07.007. Epub 2015 Jul 28.

引用本文的文献

1
The First Case of Serogroup Y and An Expanded Investigation of Healthy Carriers - Shijiazhuang City, Hebei Province, China, 2023.Y群首例病例及健康携带者扩大调查——中国河北省石家庄市,2023年
China CDC Wkly. 2024 Nov 22;6(47):1242-1247. doi: 10.46234/ccdcw2024.249.
2
Penicillin and Cefotaxime Resistance of Quinolone-Resistant Neisseria meningitidis Clonal Complex 4821, Shanghai, China, 1965-2020.1965 年至 2020 年中国上海耐青霉素和头孢噻肟的喹诺酮耐药脑膜炎奈瑟菌克隆复合体 4821 株的青霉素和头孢噻肟耐药性。
Emerg Infect Dis. 2023 Feb;29(2):341-350. doi: 10.3201/eid2902.221066.
3
Carriage prevalence of Neisseria meningitidis in China, 2005-2022: a systematic review and meta-analysis.

本文引用的文献

1
Meningococcal disease surveillance in the Asia-Pacific region (2020): The global meningococcal initiative.亚太地区脑膜炎球菌病监测(2020 年):全球脑膜炎球菌倡议。
J Infect. 2020 Nov;81(5):698-711. doi: 10.1016/j.jinf.2020.07.025. Epub 2020 Jul 27.
2
Carriage rate of Neisseria meningitidis, antibiotic susceptibility pattern and associated risk factors among primary school children in Gondar town, Northwest Ethiopia.埃塞俄比亚西北部贡德尔镇小学生中脑膜炎奈瑟菌的携带率、抗生素药敏模式及相关危险因素。
BMC Infect Dis. 2020 May 20;20(1):358. doi: 10.1186/s12879-020-05080-w.
3
[An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)].
中国 2005-2022 年脑膜炎奈瑟菌带菌率的系统评价和荟萃分析。
BMC Infect Dis. 2022 Jul 7;22(1):594. doi: 10.1186/s12879-022-07586-x.
[新型冠状病毒肺炎(COVID-19)流行病学特征的最新情况]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):139-144. doi: 10.3760/cma.j.issn.0254-6450.2020.02.002.
4
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England.英格兰婴儿接种脑膜炎 B 型疫苗(4CMenB)。
N Engl J Med. 2020 Jan 23;382(4):309-317. doi: 10.1056/NEJMoa1901229.
5
Carriage of and other species among children and young adults in Paraguay.巴拉圭儿童和青年中 及其他 物种的携带情况。
J Med Microbiol. 2019 Dec;68(12):1793-1801. doi: 10.1099/jmm.0.001097.
6
Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa.撒哈拉以南非洲脑膜炎带的脑膜炎监测和疫苗评估的未来方向。
J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S279-S285. doi: 10.1093/infdis/jiz421.
7
Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.2011-2017 年脑膜炎奈瑟菌 A 群多糖结合疫苗引入后非洲脑膜炎带的脑膜炎奈瑟菌脑膜炎暴发
J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S225-S232. doi: 10.1093/infdis/jiz355.
8
Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile.智利的 W 群脑膜炎奈瑟菌侵袭性疾病和 ACWY 结合疫苗的使用作为控制策略。
Vaccine. 2019 Oct 31;37(46):6915-6921. doi: 10.1016/j.vaccine.2019.09.050. Epub 2019 Oct 1.
9
The molecular characteristics of Neisseria meningitidis serogroup Y clonal complex 23 first emerge in China.脑膜炎奈瑟菌血清群Y克隆复合体23的分子特征首次在中国出现。
J Infect. 2019 Dec;79(6):612-625. doi: 10.1016/j.jinf.2019.07.001. Epub 2019 Jul 5.
10
Primary Meningococcal Septic Arthritis Case Report and Literature Review of an Unusual Manifestation of Meningococcal Disease.原发性脑膜炎球菌性败血症性关节炎病例报告及脑膜炎球菌病异常表现的文献综述
Bull Hosp Jt Dis (2013). 2019 Mar;77(2):140-145.